Tuesday, February 21, 2017

Molecular Psychiatry - Table of Contents alert Volume 22 Issue 3

If you are unable to see the message below, click here to view.
Molecular Psychiatry

TABLE OF CONTENTS

Volume 22, Issue 3 (March 2017)

In this issue
Image
Guest Editorial
Perspective
Immediate Communications
Review
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Image

Top

Osmotin reduced amyloid beta (Aβ) burden by inhibiting SREBP2 expression in APP/PS1 mice

S A Shah, G H Yoon, S S Chung, M N Abid, T H Kim, H Y Lee and M O Kim

Mol Psychiatry 2017 22: 323; 10.1038/mp.2017.12

Full Text | PDF

Guest Editorial

Top

Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders

C A Zarate, Jr and R Machado-Vieira

Mol Psychiatry 2017 22: 324-327; advance online publication, January 10, 2017; 10.1038/mp.2016.249

Full Text | PDF

Perspective

Top

Glutathione peroxidase 4: a new player in neurodegeneration?

B R Cardoso, D J Hare, A I Bush and B R Roberts

Mol Psychiatry 2016 22: 328-335; advance online publication, October 25, 2016; 10.1038/mp.2016.196

Abstract | Full Text | PDF

Immediate Communications

Top

GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium OPEN

J W Trampush, M L Z Yang, J Yu, E Knowles, G Davies, D C Liewald, J M Starr, S Djurovic, I Melle, K Sundet, A Christoforou, I Reinvang, P DeRosse, A J Lundervold, V M Steen, T Espeseth, K Räikkönen, E Widen, A Palotie, J G Eriksson, I Giegling, B Konte, P Roussos, S Giakoumaki, K E Burdick, A Payton, W Ollier, M Horan, O Chiba-Falek, D K Attix, A C Need, E T Cirulli, A N Voineskos, N C Stefanis, D Avramopoulos, A Hatzimanolis, D E Arking, N Smyrnis, R M Bilder, N A Freimer, T D Cannon, E London, R A Poldrack, F W Sabb, E Congdon, E D Conley, M A Scult, D Dickinson, R E Straub, G Donohoe, D Morris, A Corvin, M Gill, A R Hariri, D R Weinberger, N Pendleton, P Bitsios, D Rujescu, J Lahti, S Le Hellard, M C Keller, O A Andreassen, I J Deary, D C Glahn, A K Malhotra and T Lencz

Mol Psychiatry 2017 22: 336-345; advance online publication, January 17, 2017; 10.1038/mp.2016.244

Abstract | Full Text | PDF

Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1

A H Smith, K P Jensen, J Li, Y Nunez, L A Farrer, H Hakonarson, S D Cook-Sather, H R Kranzler and J Gelernter

Mol Psychiatry 2017 22: 346-352; advance online publication, January 24, 2017; 10.1038/mp.2016.257

Abstract | Full Text | PDF

Review

Top

Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease

T M Shah, S M Gupta, P Chatterjee, M Campbell and R N Martins

Mol Psychiatry 2017 22: 353-363; advance online publication, January 17, 2017; 10.1038/mp.2016.251

Abstract | Full Text | PDF

Original Articles

Top

A chromosome 16p13.11 microduplication causes hyperactivity through dysregulation of miR-484/protocadherin-19 signaling OPEN

M Fujitani, S Zhang, R Fujiki, Y Fujihara and T Yamashita

Mol Psychiatry 2016 22: 364-374; advance online publication, July 5, 2016; 10.1038/mp.2016.106

Abstract | Full Text | PDF

Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism

M Jiang, J Polepalli, L Y Chen, B Zhang, T C Südhof and R C Malenka

Mol Psychiatry 2016 22: 375-383; advance online publication, May 24, 2016; 10.1038/mp.2016.80

Abstract | Full Text | PDF

System-based proteomic and metabonomic analysis of the Df(16)A+/ mouse identifies potential miR-185 targets and molecular pathway alterations OPEN

H Wesseling, B Xu, E J Want, E Holmes, P C Guest, M Karayiorgou, J A Gogos and S Bahn

Mol Psychiatry 2016 22: 384-395; advance online publication, March 22, 2016; 10.1038/mp.2016.27

Abstract | Full Text | PDF

Lithium suppression of tau induces brain iron accumulation and neurodegeneration

P Lei, S Ayton, A T Appukuttan, S Moon, J A Duce, I Volitakis, R Cherny, S J Wood, M Greenough, G Berger, C Pantelis, P McGorry, A Yung, D I Finkelstein and A I Bush

Mol Psychiatry 2016 22: 396-406; advance online publication, July 12, 2016; 10.1038/mp.2016.96

Abstract | Full Text | PDF

Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer’s disease neuropathological deficits OPEN

S A Shah, G H Yoon, S S Chung, M N Abid, T H Kim, H Y Lee and M O Kim

Mol Psychiatry 2016 22: 407-416; advance online publication, March 22, 2016; 10.1038/mp.2016.23

Abstract | Full Text | PDF

Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1–PAK3 signaling in neuroplasticity

M J Kim, J Biag, D M Fass, M C Lewis, Q Zhang, M Fleishman, S P Gangwar, M Machius, M Fromer, S M Purcell, S A McCarroll, G Rudenko, R T Premont, E M Scolnick and S J Haggarty

Mol Psychiatry 2016 22: 417-429; advance online publication, July 26, 2016; 10.1038/mp.2016.98

Abstract | Full Text | PDF

High-resolution copy number variation analysis of schizophrenia in Japan

I Kushima, B Aleksic, M Nakatochi, T Shimamura, T Shiino, A Yoshimi, H Kimura, Y Takasaki, C Wang, J Xing, K Ishizuka, T Oya-Ito, Y Nakamura, Y Arioka, T Maeda, M Yamamoto, M Yoshida, H Noma, S Hamada, M Morikawa, Y Uno, T Okada, T Iidaka, S Iritani, T Yamamoto, M Miyashita, A Kobori, M Arai, M Itokawa, M -C Cheng, Y -A Chuang, C -H Chen, M Suzuki, T Takahashi, R Hashimoto, H Yamamori, Y Yasuda, Y Watanabe, A Nunokawa, T Someya, M Ikeda, T Toyota, T Yoshikawa, S Numata, T Ohmori, S Kunimoto, D Mori, N Iwata and N Ozaki

Mol Psychiatry 2016 22: 430-440; advance online publication, May 31, 2016; 10.1038/mp.2016.88

Abstract | Full Text | PDF

Transcriptome sequencing implicates dorsal striatum-specific gene network, immune response and energy metabolism pathways in bipolar disorder

R Pacifico and R L Davis

Mol Psychiatry 2016 22: 441-449; advance online publication, June 28, 2016; 10.1038/mp.2016.94

Abstract | Full Text | PDF

Intrinsic functional connectivity in late-life depression: trajectories over the course of pharmacotherapy in remitters and non-remitters OPEN

H T Karim, C Andreescu, D Tudorascu, S F Smagula, M A Butters, J F Karp, C Reynolds and H J Aizenstein

Mol Psychiatry 2016 22: 450-457; advance online publication, April 19, 2016; 10.1038/mp.2016.55

Abstract | Full Text | PDF

HCN-channel dendritic targeting requires bipartite interaction with TRIP8b and regulates antidepressant-like behavioral effects

Y Han, R J Heuermann, K A Lyman, D Fisher, Q-A Ismail and D M Chetkovich

Mol Psychiatry 2016 22: 458-465; advance online publication, July 12, 2016; 10.1038/mp.2016.99

Abstract | Full Text | PDF

Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor

J Hartmann, N Dedic, M L Pöhlmann, A Häusl, H Karst, C Engelhardt, S Westerholz, K V Wagner, C Labermaier, L Hoeijmakers, M Kertokarijo, A Chen, M Joëls, J M Deussing and M V Schmidt

Mol Psychiatry 2016 22: 466-475; advance online publication, May 31, 2016; 10.1038/mp.2016.87

Abstract | Full Text | PDF

Depression, daily stressors and inflammatory responses to high-fat meals: when stress overrides healthier food choices

J K Kiecolt-Glaser, C P Fagundes, R Andridge, J Peng, W B Malarkey, D Habash and M A Belury

Mol Psychiatry 2016 22: 476-482; advance online publication, September 20, 2016; 10.1038/mp.2016.149

Abstract | Full Text | PDF

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: